Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SERthis companySerina Therapeutics, Inc.	$1.45	-1×	-526.02×	0×	-0.88×	-94.7%	0.0%	0.0%	0.0%	51843.2%	-709.0%	-92.3%	-5.3×	0.15×	-112.78×	1.71×	0.0%	2	-3.55	2	C+
ALGSAligos Therapeutics, Inc.	$4.38	-3.8×	1.72×	42.14×	-3.45×	-97.4%	57.5%	-4024.9%	-1106.7%	-45.2%	-123.9%	-90.0%	0.1×	0.57×	0×	3.9×	0.0%	2	-16.11	2	C
CVMCEL-SCI Corporation	$1.48	-1.47×	2.34×	0×	-1.71×	-84.4%	0.0%	0.0%	0.0%	-159.2%	-97.4%	-46.0%	0.59×	0.08×	-38.23×	2.26×	0.0%	2	-38.36	2	C
GRCEGrace Therapeutics, Inc.	$1.88	-9.85×	1.2×	0×	-5.37×	-60.9%	0.0%	0.0%	0.0%	-12.2%	-14.1%	-11.6%	0×	1.53×	0×	8.1×	0.0%	2	5.07	2	C+
INMBINmune Bio, Inc.	$1.12	-0.84×	1.76×	829.46×	-0.39×	-44.6%	100.0%	-61738.0%	-91866.0%	-195.3%	-125.7%	-57.0%	0.04×	0.52×	0×	3.55×	0.0%	1	-9.17	2	C+
JUNSJupiter Neurosciences, Inc.	$2.25	-4.08×	-19.28×	1,620.54×	-4.3×	-239.6%	80.6%	-40873.2%	-39662.8%	471.9%	-255.4%	-15.3%	-2.9×	-0.18×	-134.94×	0.65×	0.0%	3	-23.07	2	C
Peer median	—	-3.8×	1.72×	42.14×	-3.45×	-84.4%	57.5%	-4024.9%	-1106.7%	-45.2%	-123.9%	-46.0%	0.04×	0.52×	0×	3.55×	0.0%	2	-16.11	2	—